Figure 3.
Forest plots of studies comparing the pooled hazard ratio for time-to-first moderate/severe exacerbation in patients with COPD receiving ICS-containing treatment or non-ICS/ICS withdrawal/placebo treatments by subgroup.
Note: (A) Eosinophil counts <2% and (B) eosinophil counts ≥2%.
Abbreviation: ICS, inhaled corticosteroid.